Evidence map›Paper›PMID 34917529›Full record

ArticleIranian journal of public health2021

Evaluation of the Outcome of Antiviral Therapy among Individuals Infected HIV-1 in Suqian District of Jiangsu Province, China.

Zhenjiang Zhang, Jing Su, Xin Shen, Bing Pei, Fang Zhu, Huichun Ji, Tingting Shi, Youde Yan

Open access · goldAbstract read
In one paragraph

Article in Iranian journal of public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhenjiang ZhangDepartment of Infectious Diseases, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, JiangSu 223800, China.
Jing SuDepartment of Hematology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, JiangSu 223800, China.
Xin ShenDepartment of Clinical Laboratory, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, JiangSu 223800, China.
Bing PeiDepartment of Clinical Laboratory, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, JiangSu 223800, China.
Fang ZhuDepartment of Infectious Diseases, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, JiangSu 223800, China.
Huichun JiDepartment of Infectious Diseases, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, JiangSu 223800, China.
Tingting ShiDepartment of Ophthalmology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, JiangSu 223800, China.
Youde YanDepartment of Infectious Diseases, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, JiangSu 223800, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate the condition of antiviral therapy (ART) for individuals infected HIV-1 in Suqian district of Jiangsu Province, China.

methodsAltogether, 561 HIV-positive patients who received antiviral therapy in Suqian district in 2019 were recruited. EDTA anticoagulated blood was collected and separated to obtain the plasma samples. Viral load (VL) were tested for evaluating the outcome of ART. Then samples with VL beyond 1000IU/mL were used to conduct the molecular test in order to master the characters of HIV-1 and the prevalence of resistance strains.

resultsVL results showed that the virus in 91.1% of the patients who received continuous antiviral treatment for more than 6 months were effectively inhibited (VL ≤ 1000 IU / ml). Among the 50 patients who failed in the treatment, 46 HIV-1 pol gene sequences were obtained, and the positive rate was 92.0%. The most prevalent strain was CRF_ 07bc (32.6%), and new epidemic strains, such as 67_01B, 79_0107, 87_cpx, were popular in this district. Drug resistance test results showed that 56.5% of the patients failed in antiviral treatment due to drug resistance, mainly resistant to the national first-line antiviral drug 3TC. Drug-resistant strains were not found in 43.5% of the patients.

conclusionART achieved a satisfied result in Suqian district, but the main cause resulting in ART-failure was resistant, so it is very necessary to enhance the education of adherence prior to the initiation of ART.

Indexed as

ChinaDrug resistant mutation sitesHIV-1Prevalence

Identifiers

PMID34917529
PMCPMC8643539
OpenAlexW3186240472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.